Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors

Radiotherapy and Oncology

Volumn 60, Issue 2, 2001, Pages 155-161

  Murata, Rumi ^a   Siemann, Dietmar W ^b   Overgaard, Jens ^a   Horsman, Michael R ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

C3H mouse mammary carcinoma; Combretastatin A 4 disodium phosphate; KHT mouse sarcoma; Radiation; Vascular targeting

Indexed keywords

COMBRETASTATIN A4; HOE 33342; RUBIDIUM CHLORIDE RB 86;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL INJURY; BREAST CARCINOMA; CANCER CONTROL; CANCER RADIOTHERAPY; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; RADIATION RESPONSE; SARCOMA; SKIN DEFECT; TISSUE INJURY; TREATMENT OUTCOME; TUMOR BLOOD FLOW; TUMOR MODEL; TUMOR NECROSIS; TUMOR VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; COMBINED MODALITY THERAPY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; NECROSIS; NEOPLASM TRANSPLANTATION; SARCOMA, EXPERIMENTAL; STILBENES;

EID: 0034962379     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(01)00384-X     Document Type: Article

References (26)

1. Antivascular approaches to solid tumor therapy: Evaluation of tubulin binding agents
2. Tumor vasculature as a target for cancer therapy
3. Anti-vascular approaches to solid tumor therapy: Evaluation of combretastatin A4 phosphate
4. Area and volume measurements by random sampling methods
5. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature
6. Angiogenic attack as a therapeutic strategy for cancer
7. 15O decay after photon activation in situ
8. The influence of radiation dose on the magnitude and kinetics of reoxygenation in a C3H mammary carcinoma
9. Microvasculature of C3H/Bi mouse mammary tumors after X-irradiation
10. The effect of combining flavone acetic acid and hyperthermia on the growth of a C3H mammary carcinoma in vivo
11. The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors
12. Reoxygenation in a C3H mouse mammary carcinoma: The importance of chronic rather than acute hypoxia
13. Combretastatins: Novel vascular targeting drugs for improving anti-cancer therapy
14. Improving local tumor control by combining vascular targeting drugs, mild hyperthermia and radiation
15. The in vivo interaction between flavone acetic acid and hyperthermia
16. Blood flow in irradiated mouse sarcoma as determined by the clearance of Xenon-133
17. Targeting the tumor vasculature with combretastatin A-4 disodium phosphate: Effects on radiation therapy
18. 1H MRI
19. Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumor and normal tissues
20. Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo
21. Antineoplastic agents 322. Synthesis of combretastatin A-4 prodrugs
22. Regional blood flow by fractional distribution of indicators
23. Chemosensitization of CCNU in KHT murine tumor cells in vivo and in vitro by the agent RB 6145 and its isomer PD 144872
24. Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumors
25. An in vitro assay to measure the viability of KHT tumor cells not previously exposed to culture conditions
26. Combretastatin A-4 phosphate as a tumor vascular-targeting agent: Early effects in tumors and normal tissues